A. Aktipis, Life history trade-offs in cancer evolution, Nature Rev. Cancer, vol.13, pp.883-892, 2013.

A. Aktipis, Cancer across the tree of life: cooperation and cheating in multicellularity, Phil. Trans. R. Soc. B, vol.370, 2015.
URL : https://hal.archives-ouvertes.fr/hal-02191687

L. Almeida, Evolution of cancer cell populations under cytotoxic therapy and treatment optimisation: insight from a phenotype-structured model, ESAIM Math. Model. Numer. Anal, 2018.

D. Basanta, Investigating prostate cancer tumourstroma interactions: clinical and biological insights from an evolutionary game, British Journal of Cancer, vol.106, issue.1, pp.174-181, 2011.

C. Basdevant, Optimisation of time-scheduled regimen for anti-cancer drug infusion, ESAIM Math. Model. Numer. Anal, vol.39, issue.6, pp.1069-1086, 2005.

E. Bouin, Invasion fronts with variable motility: Phenotype selection, spatial sorting and wave acceleration, C. R. Acad. Sci. Paris, Ser. I, pp.761-766, 2012.
URL : https://hal.archives-ouvertes.fr/hal-00716349

T. Boveri, The origins of malignant tumors, 1929.

N. F. Britton, Essential Mathematical Biology, 2003.

B. Brutovsky and &. Horvath, Structure of Intratumor Heterogeneity: Is Cancer Hedging Its Bets? arXiv, 2013.

C. Burz, Circulating tumor cells in clinical research and monitoring patients with colorectal cancer, Oncotarget, vol.9, issue.36, pp.24561-24571, 2018.

K. J. Bussey, Ancestral gene regulatory networks drive cancer, vol.114, pp.6160-6162, 2017.

C. Carrère, Optimization of an in vitro chemotherapy to avoid resistant tumours, J. Theor. Biol, vol.413, pp.24-33, 2017.

R. H. Chisholm, Emergence of drug tolerance in cancer cell populations: an evolutionary outcome of selection, non-genetic instability and stress-induced adaptation, Cancer Research, vol.75, issue.6, pp.930-939, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01111271

R. H. Chisholm, Cell population heterogeneity and evolution towards drug resistance in cancer: Biological and mathematical assessment, theoretical treatment optimisation, Biochem. Biophys. Acta, vol.1860, pp.2627-2645, 2016.

R. H. Chisholm, Effects of an advection term in nonlocal Lotka-Volterra equations, Comm. Math. Sciences, vol.14, pp.1181-1188, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01237529

H. Cho and &. D. Levy, Modeling continuous levels of resistance to multidrug therapy in cancer, Appl. Math. Model, vol.64, pp.733-751, 2018.

H. Cho and &. D. Levy, Modeling the chemotherapy-induced selection of drug-resistant traits during tumor growth, J. Theor. Biol, vol.436, issue.7, pp.120-134, 2018.

P. Cirri and &. Chiarugi, Cancer associated fibroblasts: the dark side of the coin, Am. J. Cancer Research, vol.1, issue.4, pp.482-497, 2011.

L. H. Cisneros, Ancient genes establish stressinduced mutation as a hallmark of cancer, PLoS One, vol.12, issue.4, p.176258, 2017.

J. Clairambault and &. Fercoq, Physiologically structured cell population dynamic models with applications to combined drug delivery optimisation in oncology, Mathematical Modelling of Natural Phenomena, vol.11, issue.6, pp.45-70, 2016.
URL : https://hal.archives-ouvertes.fr/hal-00750633

A. S. Cleary, Tumour cell heterogeneity maintained by cooperating subclones in Wnt-driven mammary cancers, Nature Lett, vol.508, pp.113-117, 2014.

M. I. Costa, Optimal chemical control of populations developing drug resistance, Mathematical Medicine and Biology, vol.9, issue.3, pp.215-226, 1992.

P. C. Davies-&-c and . Lineweaver, Cancer tumors as metazoa 1.0: tapping genes of ancient ancestors, Phys. Biol, vol.8, issue.1, p.15001, 2011.

L. Desvillettes, On selection dynamics for continuous structured populations, Commun. Math. Sci, vol.6, issue.3, pp.729-747, 2008.
URL : https://hal.archives-ouvertes.fr/hal-00363138

L. Ding, Clonal evolution in relapsed acute myeloid leukaemia revealed by whole genome sequencing, Nature, vol.481, pp.506-510, 2012.

B. Dirat, Cancer-associated adipocytes exhibit an activated phenotype and contribute to breast cancer invasion, Cancer Research, issue.7, pp.2455-2465, 2011.
URL : https://hal.archives-ouvertes.fr/inserm-00819288

T. Dobzhansky, Biology, molecular and organismic, vol.4, pp.443-452, 1964.

T. Domazet-lo?o and &. D. Tautz, An ancient evolutionary origin of genes associated with human genetic diseases, Mol. Biol. Evol, vol.25, issue.12, pp.2699-2707, 2008.

T. Domazet-lo?o and &. D. Tautz, Phylostratigraphic tracking of cancer genes suggests a link to the emergence of multicellularity in metazoa, BMC Biol, vol.8, issue.1, p.66, 2010.

H. Easwaran, Cancer Epigenetics: Tumor Heterogeneity, Plasticity of Stem-like States, and Drug Resistance, Molecular Cell, vol.54, pp.716-727, 2014.

A. P. Feinberg, Epigenetic modulators, modifiers and mediators in cancer aetiology and progression, Nature Rev. Genet, vol.17, issue.5, pp.284-99, 2016.

R. A. Gatenby, Adaptive therapy, Cancer Research, vol.69, issue.11, pp.4894-4903, 2009.
URL : https://hal.archives-ouvertes.fr/hal-01887358

M. Gerlinger, Intratumor heterogeneity and branched revealed by multiregion sequencing, N Engl J Med, vol.366, issue.10, pp.883-892, 2012.

M. Gerlinger and &. Swanton, How darwinian models inform therapeutic failure initiated by clonal heterogeneity in cancer medicine, Br J Cancer, vol.103, issue.8, pp.1139-1143, 2010.

R. J. Gillies, Evolutionary dynamics of carcinogenesis and why targeted therapy does not work, Nature Rev. Cancer, vol.12, issue.7, pp.487-493, 2012.

A. Goldman, Integrating Biological and Mathematical Models to Explain and Overcome Drug Resistance in Cancer, Part 1: Biological Facts and Studies in Drug Resistance, Current Stem Cell Reports, vol.3, pp.253-259, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01574685

A. Goldman, Integrating Biological and Mathematical Models to Explain and Overcome Drug Resistance in Cancer, Part 2: From Theoretical Biology to Mathematical Models, Current Stem Cell Reports, vol.3, pp.260-268, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01558479

M. M. Gottesman, Mechanisms of cancer drug resistance, Annu Rev Med, vol.53, pp.615-627, 2002.

M. Greaves, Cancer stem cells: back to Darwin?, Semin Cancer Biol, vol.20, issue.2, pp.65-70, 2010.

M. C. Greaves-&-c and . Maley, Clonal evolution in cancer, Nature, vol.481, issue.7381, pp.306-313, 2012.

C. A. Gravenmier, Adaptation to Stochastic Temporal Variations in Intratumoral Blood Flow: The Warburg Effect as a Bet Hedging Strategy, Bull Math Biol, vol.80, issue.5, pp.954-970, 2017.

G. D. Guler, Repression of Stress-Induced LINE-1 Expression Protects Cancer Cell Subpopulations from Lethal Drug Exposure, Cancer Cell, vol.32, pp.221-237, 2017.

P. Hirsch, Genetic hierarchy and temporal variegation in the clonal history of acute myeloid leukaemia, Nature Comm, vol.7, p.12475, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01358183

S. Huang, Bifurcation dynamics in lineagecommitment in bipotent progenitor cells, Dev Biol, vol.305, issue.2, pp.695-713, 2007.

S. Huang, On the intrinsic inevitability of cancer: From foetal to fatal attraction, Sem. Canc. Biol, vol.21, pp.183-199, 2011.

S. Huang, Genetic and non-genetic instability in tumor progression: link between the fitness landscape and the epigenetic landscape of cancer cells, Canc. Metastasis Rev, vol.32, pp.423-448, 2013.

L. Israel, Tumour progression: random mutations or an integrated survival response to cellular stress conserved from unicellular organisms?, J. Theor. Biol, vol.178, issue.4, pp.375-380, 1996.

P. E. Jabin and &. G. Raoul, On selection dynamics for competitive interactions, J. Math. Biol, vol.63, pp.493-551, 2011.
URL : https://hal.archives-ouvertes.fr/hal-00602077

F. Jacob, Evolution and tinkering, Science, vol.196, issue.4295, pp.1161-1166, 1977.

M. Kimmel and &. ?wierniak, Control Theory Approach to Cancer Chemotherapy: Benefiting from Phase Dependence and Overcoming Drug Resistance, Tutorials in Mathematical Biosciences III, Avner Friedman, 2006.

R. K. Konopka and &. S. Benzer, Clock mutants of drosophila melanogaster, Proc Natl Acad Sci, vol.68, pp.2112-2116, 1971.

O. Lavi, The role of cell density and intratumoral heterogeneity in multidrug resistance, Cancer Res, vol.73, issue.24, pp.7168-7175, 2013.

U. ??d?ewicz, On the role of tumor heterogeneity for optimal cancer chemotherapy, Networks & Heterogeneous Media, vol.14, issue.1, pp.131-147, 2019.

H. Li, Circulating tumor DNA detection: A potential tool for colorectal cancer management, Oncology Letters, vol.7, issue.2, pp.1409-1416, 2019.

C. H. Lineweaver, Targeting cancer's weaknesses (not its strengths): therapeutic strategies suggested by the atavistic model, Bioessays, vol.36, issue.9, pp.827-835, 2014.

T. Lorenzi, Dissecting the dynamics of epigenetic changes in phenotype-structured populations exposed to fluctuating environments, Journal of Theoretical Biology, vol.386, pp.166-176, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01237890

T. Lorenzi, Tracking the evolution of cancer cell populations through the mathematical lens of phenotypestructured equations, Biology Direct, vol.11, p.43, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01321535

A. Lorz, Populational adaptive evolution, chemotherapeutic resistance and multiple anti-cancer therapies, ESAIM Math. Model. Numer. Anal, vol.47, issue.2, pp.377-399, 2013.
URL : https://hal.archives-ouvertes.fr/hal-00714274

A. Lorz, Modeling the effects of space structure and combination therapies on phenotypic heterogeneity and drug resistance in solid tumors, Bull. Math. Biol, vol.77, issue.1, pp.1-22, 2014.
URL : https://hal.archives-ouvertes.fr/hal-00921266

Y. Manabe, Mature adipocytes, but not preadipocytes, promote the growth of breast carcinoma cells in collagen gel matrix culture through cancerstromal cell interactions, The Journal of pathology, vol.201, issue.2, pp.221-228, 2003.

A. Marusyk, Intra-tumour heterogeneity: a looking glass for cancer?, Nature Rev. Cancer, vol.12, pp.323-334, 2012.

A. Marusyk, Non-cell-autonomous driving of tumour growth supports sub-clonal heterogeneity, Nature, vol.514, pp.54-58, 2014.

J. Maynard, Smith & Eös Szathmáry. The Major Transitions in Evolution, 1997.

K. D. Mccullough, Plasticity of the neoplastic phenotype in vivo is regulated by epigenetic factors, Proc Natl Acad Sci, vol.95, issue.26, pp.15333-15338, 1998.

R. E. Michod and &. D. Roze, Cooperation and conflict in the evolution of multicellularity, Heredity, vol.36, pp.1-7, 2001.

R. E. Michod and &. D. Roze, Cooperation and conflict during evolutionary transitions in individuality, J. Evol. Biol, vol.19, pp.1406-1409, 2006.

R. E. Michod, Life-history evolution and the origin of multicellularity, J. Theor. Biol, vol.239, pp.257-272, 2006.

W. E. Müller-&-i and . Müller, Origin of the Metazoan Immune System: Identification of the Molecules and Their Functions in Sponges, Integrative Comparative Biology, vol.43, pp.281-292, 2003.

J. D. Murray, Mathematical biology, vol.2, 2002.

T. N. Nguyen, Adaptive dynamics of hematopoietic stem cells and their supporting stroma: A model and mathematical analysis, 2019.
URL : https://hal.archives-ouvertes.fr/hal-01963820

P. C. Nowell, The clonal evolution of tumor cell populations, Science, vol.194, issue.4260, pp.23-28, 1976.

A. Olivier and &. Pouchol, Combination of direct methods and homotopy in numerical optimal control: application to the optimization of chemotherapy in cancer, Journal of Optimization Theory and Applications, 2018.
URL : https://hal.archives-ouvertes.fr/hal-01568779

E. Pasquier, Metronomic chemotherapy: new rationale for new directions, Nature Rev. Clin. Oncol, vol.7, issue.8, pp.455-465, 2010.

B. Perthame, Transport equations in biology, 2007.

B. Perthame, Parabolic equations in biology, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01423552

A. O. Pisco, Non-darwinian dynamics in therapyinduced cancer drug resistance, Nat. Commun, vol.4, p.2467, 2013.

A. O. Pisco and &. S. Huang, Non-genetic cancer cell plasticity and therapy-induced stemness in tumour relapse: 'What does not kill me strengthens me', Br J Cancer, vol.112, issue.11, pp.1725-1732, 2015.

M. Plankar, On the origin of cancer: Can we ignore coherence?, Progress in Biophysics and Molecular Biology, vol.106, issue.2, pp.380-390, 2011.

K. Polyak and &. Marusyk, Clonal cooperation, Nature, vol.508, pp.52-53, 2014.

C. , Modelling interactions between tumour cells and supporting adipocytes in breast cancer, Internship report available at, 2015.

C. Pouchol, Asymptotic analysis and optimal control of an integro-differential system modelling healthy and cancer cells exposed to chemotherapy, J. Math. Pures Appl, vol.116, pp.268-308, 2018.
URL : https://hal.archives-ouvertes.fr/hal-01416594

C. Pouchol and &. E. Trélat, Global stability with selection in integro-differential Lotka-Volterra systems modelling trait-structured populations, Journal of Biological Dynamics, vol.12, issue.1, pp.872-893, 2018.
URL : https://hal.archives-ouvertes.fr/hal-01470722

C. , Analysis, control and optimisation of PDEs, application to the biology and therapy of cancer, 2018.

S. M. Reppert-&-d and . Weaver, Coordination of circadian timing in mammals, Nature, vol.418, pp.935-941, 2002.

T. Rich, Elevated serum cytokines correlated with altered behavior, serum cortisol rhythm, and dampened 24-hour rest-activity pattern in patients with metastatic colorectal cancer, Clinical Cancer Research, vol.11, pp.1757-1764, 2005.

H. Schättler and &. ??d?ewicz, Optimal Control for Mathematical Models of Cancer Therapies, 2015.

U. Schibler-&-p.-sassone-corsi, A web of circadian pacemakers, Cell, vol.111, pp.919-922, 2002.

S. V. Sharma, A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations, Cell, vol.141, issue.1, pp.69-80, 2010.

L. Sigalotti, Epigenetic drugs as immunomodulators for combination therapies in solid tumors, Pharmacology & Therapeutics, vol.142, pp.339-350, 2014.

A. M. Soto and &. Sonnenschein, The somatic mutation theory of cancer: growing problems with the paradigm?, BioEssays, vol.26, issue.10, pp.1097-1107, 2004.

G. W. Swan, Role of Optimal Control Theory in Cancer Chemotherapy, Mathematical Biosciences, vol.101, pp.237-284, 1990.

D. P. Tabassum and &. Polyak, Tumorigenesis: it takes a village, Nature Rev. Cancer, vol.15, pp.473-483, 2015.

G. Tonini, Rechallenge therapy and treatment holiday: different strategies in management of metastatic colorectal cancer, Journal of experimental & clinical cancer research, vol.32, issue.1, p.1, 2013.

K. M. Towe, Oxygen-collagen priority and the early metazoan fossil record, Proc Natl Acad Sci, vol.65, issue.4, pp.781-788, 1970.

K. M. Towe, Biochemical keys to the emergence of complex life, Life in the Universe, pp.297-305, 1981.

E. Trélat, Optimal control and applications to aerospace: some results and challenges, Journal of Optimization Theory and Applications, vol.154, pp.713-758, 2012.

A. S. Trigos, Altered interactions between unicellular and multicellular genes drive hallmarks of transformation in a diverse range of solid tumors, vol.114, pp.6406-6411, 2017.

A. S. Trigos, How the evolution of multicellularity set the stage for cancer, Br. J. Cancer, vol.118, pp.145-152, 2018.

J. E. Trosko, Mechanisms of tumor promotion: possible role of inhibited intercellular communication, Eur. J. Cancer Clin. Oncol, vol.23, issue.6, pp.599-601, 1987.

J. E. Trosko, Rosetta Stone" in Understanding, in a Systems Biological Manner, Stem Cell Behavior, Mechanisms of Epigenetic Toxicology, Chemoprevention and Chemotherapy, Gap Junctional Intercellular Communication as a Biological, vol.218, pp.93-100, 2007.

J. E. Trosko, A conceptual integration of extra-, intraand gap junctional-intercellular communication in the evolution of multi-cellularity and stem cells: how disrupted cell-cell communication during development can affect diseases later in life, Int. J. Stem Cell Res. Ther, vol.3, issue.1, p.21, 2016.

, Ecology and evolution of cancer, 2017.

M. D. Vincent, Cancer: a de-repression of a default survival program common to all cells?: a life-history perspective on the nature of cancer, Bioessays, vol.34, issue.1, pp.72-82, 2011.

M. D. Vincent, Cancer beyond speciation, Advances in cancer research, vol.112, pp.283-350, 2011.
DOI : 10.1016/b978-0-12-387688-1.00010-7

M. H. Vitaterna, Mutagenesis and mapping of a mouse gene, clock, essential for circadian behavior, Science, vol.264, pp.719-725, 1994.

C. H. Waddington, The strategies of the genes, George Allen & Unwin, 1957.

A. Wu, Ancient hot and cold genes and chemotherapy resistance emergence, Proc. Nat. Acad. Sci. USA, vol.112, pp.10467-10472, 2015.
DOI : 10.1073/pnas.1512396112

URL : http://www.pnas.org/content/112/33/10467.full.pdf

J. X. Zhou, Phylostratigraphic analysis of tumor and developmental transcriptomes reveals relationship between oncogenesis, phylogenesis and ontogenesis, Converg. Sci. Phys. Oncol, vol.4, p.25002, 2018.